US Merger & Acquisition SEC Filings — October 16, 2026

Completed cash tender at $10.50 per share with 116,818,409 ACV shares (~68.43%) validly tendered; ACV delisted from NYSE and runs as an independent subsidiary under existing leadership, supporting a clean integration thesis

Fifth of six permitted extensions, deadline moved from October 19 to November 19, 2026 with only one extension remaining, indicating no target business combination yet and sponsor reliance on rolling extensions

Extraordinary general meeting postponed from October 16 to October 23, 2026 to vote on extending its business combination deadline; existing proxies remain valid and redemption withdrawals remain open, a neutral procedural signal with redemption-risk optionality

Asset purchase from PlayJamaica closed October 14, 2026 for 22,500 Series B Preferred shares (stated value $225,000) plus up to $3,000,000 earn-out in four $750,000 tranches tied to $500K, $1.5M, $3M and $5M revenue thresholds, so most consideration is contingent on performance

Employment packages grant up to 100,000,000 common shares to Gregory and Ryan Moore (50M each, three-year vesting), a material dilution event that the filing does not quantify against outstanding shares

Consideration is all-cash with no stock component, meaning Copart's share count is unaffected and the deal's value to Copart shareholders depends on post-close synergies rather than dilution

Director Mary Szela resigned October 16, 2026 from the Board and two committees, not due to disagreement; Graeme Bell and Akiko Moni Miyashita were appointed same day, a routine governance change with no financial implications

Only one of six permitted extensions remains after November 19, 2026, implying a hard liquidation or business-combination deadline in late 2026 or early 2027 if no target is announced

Up to 100,000,000 common shares granted to two executives is material to a micro-cap, and total outstanding shares were not disclosed, so the true dilution percentage cannot be assessed from this filing

Company commits up to $1,000,000 of capital to the subsidiary, funded by a planned Regulation A offering that is not yet completed, creating execution risk on the entire growth plan

Most of the PlayJamaica consideration ($3M of earn-out) depends on revenue reaching $5M cumulatively, so the acquired business must scale materially before the seller is paid in full

The purchase agreement allows termination if closing has not occurred by December 31, 2026, yet the filing states closing occurred October 14, 2026, a disclosure inconsistency worth verifying

The shareholder meeting on extending the business combination deadline was postponed one week, and redemption withdrawals remain possible until the rescheduled meeting, adding uncertainty to the trust balance

Loss of an audit committee member and compensation committee chair, even with same-day replacements, can signal governance or sponsor-side friction in a blank-check company, though the filing states no disagreement

With ACV operating as an independent subsidiary under existing leadership and all ACV shares converted to cash, Copart can capture marketplace and auction synergies without a stock-based dilution drag

Copart stated it will promptly pay for tendered shares; the closing of a $10.50 cash deal removes execution uncertainty for the ~68% tendered and the remaining converted shares, creating a clean event for merger-arbitrage positions that have already closed out

The rescheduled October 23, 2026 meeting is a clear near-term catalyst; approval of the deadline extension would keep the life-sciences SPAC alive for a target combination, while a failed vote would trigger redemptions and a trust-value event

Each $750,000 earn-out tranche unlocks only when cumulative PlayJamaica revenue crosses $500K, $1.5M, $3M or $5M, so a rapidly growing acquired business would convert contingent consideration into real shareholder value over time

The 22,500 Series B Preferred shares issued for the asset deal provide a senior claim structure that could be leveraged for future financing, though the security terms are not detailed in the filing

With the extension to November 19 and only one remaining, management has a strong incentive to announce a target in the coming weeks, creating a potential event-driven catalyst for the BAYAR rights and underlying shares

Copart's completed $10.50 per share cash acquisition of ACV Auctions (68.43% tendered) shows strategic buyers paying cash to absorb digital auction platforms, consistent with consolidation in vehicle remarketing and online marketplaces

Two of the four SPAC or blank-check filings (Bayview on its fifth extension and Oaktree III on a deadline-extension vote) show sponsors relying on repeated deadline relief, implying that the 2026 SPAC cohort is struggling to complete combinations on original timetables

Averin Capital's Item 5.02 board and committee change adds to a pattern of routine but frequent director turnover at small SPACs, where audit and compensation committee seats are often refilled with limited disclosure

AIBOTICS' asset purchase uses preferred stock, a contingent earn-out and up to 100 million employee shares rather than cash, illustrating how micro-caps pay for acquisitions with equity and performance-based consideration instead of balance-sheet capacity

Extraordinary general meeting on extending the business combination deadline, rescheduled to October 23, 2026 at 10:00 a.m. ET; in-person attendance must be reserved by October 21 [DATE: 2026-10-23]

Extension deadline moves to November 19, 2026; watch for a definitive business combination announcement before the last permitted extension is consumed [DATE: 2026-11-19]

Confirm payment of tendered shares and the post-close operating structure of ACV as an independent Copart subsidiary, with any updates to synergy or leadership disclosures [DATE: TBD]

Verify the closing date discrepancy against the December 31, 2026 outside date in the purchase agreement, and monitor disclosure of outstanding share count to quantify the 100 million share grant [DATE: 2026-12-31]

Status of the planned Regulation A offering that funds up to $1,000,000 of subsidiary capital, the key dependency for the acquired business [DATE: TBD]

Tracking cumulative PlayJamaica revenue against the $500K, $1.5M, $3M and $5M thresholds that trigger the four $750,000 earn-out tranches [DATE: TBD]

Newly appointed Compensation Committee chair Graeme Bell and Audit Committee member Akiko Moni Miyashita; monitor for any further board turnover or a business combination announcement [DATE: 2026-10-16]